Ananda Pharma Plc (AQU: ANA)

London flag London · Delayed Price · Currency is GBP · Price in GBX
0.435
+0.010 (2.35%)
At close: Jan 24, 2025
33.85%
Market Cap 18.70M
Revenue (ttm) 764.00
Net Income (ttm) -6.37M
Shares Out 4.30B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open n/a
Previous Close 0.425
Day's Range n/a
52-Week Range n/a
Beta 0.87
RSI 49.12
Earnings Date Jan 29, 2025

About Ananda Pharma

Ananda Pharma Plc, together with its subsidiaries, invests in the medicinal and therapeutic cannabis market in the United Kingdom and internationally. The company provides cannabinoid-based medicines for the treatment of chronic inflammatory pain conditions. It also grows melon and root tubers; develops and distributes health products; wholesales pharmaceutical goods; manufactures and sells organic basic and essential oils; and is involved in crop production activities. The company was formerly known as Ananda Developments Plc and changed its n... [Read more]

Industry Pharmaceutical Preparations
Founded 2018
Employees 12
Stock Exchange Aquis Exchange
Ticker Symbol ANA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.